Institutional Enrollment and Survival Among NSCLC Patients Receiving Chemoradiation: NRG Oncology Radiation Therapy Oncology Group (RTOG) 0617

Conclusion: Treatment at institutions with higher clinical trial accrual volume is associated with longer OS among patients with LA-NSCLC participating in a phase III trial.

Source: JNCI - May 18, 2016 Category: Cancer & Oncology Authors: Eaton, B. R., Pugh, S. L., Bradley, J. D., Masters, G., Kavadi, V. S., Narayan, S., Nedzi, L., Robinson, C., Wynn, R. B., Koprowski, C., Johnson, D. W., Meng, J., Curran, W. J. Tags: Article Source Type: research